Similarly, a biodegradable tumor-targeting nanocarrier designed to release Fenton-like Cu2+/Cu enhances GSH depletion, inhibits catalase (CAT) activity, and promotes the generation of hydroxyl radicals (•OH), ultimately leading to tumor apoptosis (Lu et al., 2022). The gene discussed is CAT; the disease is neoplasm.